IndiaOne Finance - Company Dashboard

Governance Classic Home

Fredun Pharmaceuticals LtdPharmaceuticalsINE194R01017Standalone₹1305.85+27.20 (+2.13%)Jun-26

Valuation

Market Cap₹2.16K Cr

TTM PE15.50x

Forward PE46.65x

PEG0.39

Book Value₹85.49

P/B15.28x

TTM EPS₹84.25

Fwd EPS₹28.00

TTM Revenue₹741.69 Cr

TTM PAT₹44.45 Cr

TTM EBITDA₹104.75 Cr

TTM EBIT₹94.69 Cr

Last Qtr PAT₹13.17 Cr

Last Qtr EBITDA₹32.29 Cr

Last Qtr EBIT₹28.72 Cr

Profitability

ROE31.44%

ROCE33.00%

TTM NPM5.99%

TTM EBITDA %14.12%

Curr OPM5.78%

Last OPM5.26%

Curr NPM—

Last NPM—

Curr EPS₹7.88

Last EPS₹6.67

Balance sheet

Equity₹4.72 Cr

Reserve₹136.66 Cr

Total Debt₹167.14 Cr

D/E1.18x

Interest %65.45%

Curr Interest₹8.62 Cr

Price / range

Close₹1305.85

vs 52W High-18.38%

vs 52W Low+53.32%

MA50—

MA200—

Returns

1D+2.13%

1W-7.62%

1M-9.50%

3M+49.78%

6M+142.58%

1Y+218.02%

2Y+409.44%

3Y+334.47%

5Y+770.74%

Diwali-15.00%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	227.76+90.8%	210.41	159.93	143.59	119.40	633.33
Other Income	0.49	2.64	1	1.71	0.45	5.80
Total Income	228.25+90.4%	213.05	160.92	145.29	119.86	639.12
Interest	8.62	14.49	10.55	7.73	6.53	39.30
Expenditure	-207.66-87.4%	-201.52	-146.92	-132.29	-110.80	-591.54
PBDT	0	0	0	0	0	0
EBITDA	32.29+95.1%	26.49	25.34	20.63	16.55	89
Depreciation	-3.57	-3.11	-1.78	-1.60	-1.42	-7.91
EBIT	28.72+89.8%	23.38	23.56	19.03	15.13	81.09
PBT	20.59+127.8%	11.53	14	13.01	9.04	47.58
Tax	-7.42	-0.47	-3.52	-3.27	-2.20	-14.38
Equity	0	0	0	0	0	0
OPM	9.04	5.48	8.76	9.06	7.57	7.00
Net Profit	13.17+94.5%	11.07	10.48	9.73	6.77	33.21
NPM	5.78	5.26	6.55	6.78	5.67	5.00
EPS	23.89	20.22	19.53	20.61	0	68.01

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	633.33+40.2%	451.71+30.3%	346.58+26.3%	274.34+23.7%	221.74+68.6%	131.55
Other Income	5.80	4.56	2.50	2.16	4.35	3.74
Total Income	639.12+40.1%	456.27+30.7%	349.07+26.2%	276.50+22.3%	226.09+67.1%	135.29
Expenditure	-591.54-38.2%	-428-30.6%	-327.62-26.5%	-258.99-19.1%	-217.49-66.1%	-130.92
Interest	-39.30	-22.38	-13.65	-9.28	-4.67	-4.16
PBDT	0	0	0	0	0	0
EBITDA	89+76.1%	50.54+38.8%	36.41+32.7%	27.44+147.7%	11.08+63.2%	6.79
Depreciation	-7.91	-4.45	-3.80	-2.81	-2.16	-2
EBIT	81.09+75.9%	46.09+41.3%	32.61+32.4%	24.63+176.1%	8.92+86.2%	4.79
PBT	47.58+68.3%	28.27+31.8%	21.45+22.5%	17.51+103.6%	8.60+167.9%	3.21
Tax	-14.38	-7.46	-5.83	-6.70	-2.27	-1.19
Equity	0	4.72	0	0	0	0
OPM (%)	7.00	6.20	6.00	6.00	4.00	2.00
Net Profit	33.21+59.6%	20.81+33.2%	15.62+44.5%	10.81+70.5%	6.34+213.9%	2.02
NPM (%)	5.00	4.56	4.00	4.00	3.00	1.00
EPS (Rs)	68.01+51.7%	44.83+33.2%	33.66+46.8%	22.93+60.5%	14.29+183.0%	5.05
CEPS	62.33	44.83	33.32	22.93	14.29	5.05

Metric	Dec-25	Jun-25	Mar-25	FY24-25
Revenue	159.93	119.40	165.44	451.71
Other Income	1	0.45	1.97	4.56
Total Income	160.92	119.86	167.41	456.27
Interest	10.55	6.53	8.15	22.38
Expenditure	-146.92	-110.80	-160.10	-428.78
PBDT	0	0	0	0
EBITDA	25.34	16.55	15.33	50.35
Depreciation	-1.78	-1.42	-1.84	-5.04
EBIT	23.56	15.13	13.49	45.31
PBT	14	9.04	7.26	27.49
Tax	-3.52	-2.20	-1.20	-7.75
Equity	0	0	0	4.72
OPM	8.70	7.54	4.34	6.03
Net Profit	10.48	6.77	6	19.74
NPM	6.51	5.65	3.59	4.33
EPS	19.53	14.33	12.71	44.83

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25
Revenue	451.71
Other Income	4.56
Total Income	456.27
Expenditure	-428.78
Interest	-22.38
PBDT	0
EBITDA	50.35
Depreciation	-5.04
EBIT	45.31
PBT	27.49
Tax	-7.75
Equity	4.72
OPM (%)	6.03
Net Profit	19.74
NPM (%)	4.33
EPS (Rs)	44.83
CEPS	44.83

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.7	23 Jun 2026
2025	Final Dividend	0.7	23 Sep 2025
2024	Final Dividend	0.7	23 Sep 2024
2023	Final Dividend	0.7	22 Sep 2023
2021	Final Dividend	0.7	16 Sep 2021
2019	Final Dividend	0.65	16 Sep 2019
2018	Final Dividend	0.6	18 Sep 2018
2017	Final Dividend	0.6	20 Sep 2017
2017	Interim Dividend	0.6	11 Apr 2016

Bonus

Year	Ratio	Ex-Date
2026	2:1	16 Jul 2026

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split